Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06900296 · ClinicalTrials.gov registry record
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)
A clinical trial, sponsored by Indiana University.
- Not yet
- Registry status
- 100
- Enrollment target
NCT06900296 is a clinical trial that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 100 participants.
The verdict
NCT06900296 has not yet begun recruiting, sponsored by Indiana University.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a prospective observational study that will collect blood samples at 1-10 timepoints related to initiation of immunotherapy. The study may collect samples before the start of immunotherapy and/or at clinically significant timepoints during immunotherapy treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-05 |
| Est. Completion | 2029-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06900296
The ClinicalTrials.gov registry entry for NCT06900296 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06900296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06900296 about?
NCT06900296 is a clinical study titled "ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)". This is a prospective observational study that will collect blood samples at 1-10 timepoints related to initiation of immunotherapy. The study may collect samples before the start of immunotherapy and/or at clinically significant timepoints during immunotherapy treatment.
What is the current status of trial NCT06900296?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-05. Estimated completion is 2029-04.
Who is sponsoring clinical trial NCT06900296?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.